Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON43053
NL-OMON43053
Completed
Phase 4

Preventing contrAst induced Nephropathy after TranscathEter aortic valve Replacement - PANTER

Sint Antonius Ziekenhuis0 sites200 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsaortic stenosiskidney injury1004697310029149

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
aortic stenosis
Sponsor
Sint Antonius Ziekenhuis
Enrollment
200
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\. Patient has provided written informed consent.
  • •2\. Patient is undergoing TAVI.
  • •3\. Patient has an estimated GFR \<60ml/min/1\.73m2\.

Exclusion Criteria

  • •1\. Patient has end\-stage kidney disease requiring dialysis.
  • •2\. Emergent TAVI (planned before next working day).
  • •3\. Recent exposure to radiographic contrast agents (within 2 days prior to the TAVI).
  • •4\. Allergy to contrast agent.
  • •5\. Planned administration of dopamine, mannitol, fenoldopam or N\-acetylcysteine during the intended time of the study.
  • •6\. Need for continuous hydration therapy (e.g. sepsis).
  • •7\. Multiple myeloma.
  • •8\. Contra\-indication to sodium bicarbonate.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
N/A
Prevention of Contrast Induced Nephropathy after Endovascular Therapy combined with Carbon Dioxide-digital subtraction angiography in Patients With Ilio-Femoropopliteal artery diseasesperipheral artery disease
JPRN-UMIN000011988Sakakibara Heart Institute100
Completed
N/A
PREVENTion of Contrast-Induced Nephropathy after Cardiovascular catheterization and intervention by high dose statin therapy in JapaCoronary artery disease with dyslipidemia and chronic kidney disease
JPRN-UMIN000021695ara Medical University420
Completed
N/A
Protection against acute renal failure following cardiac surgery
ISRCTN98672577Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)1,100
Recruiting
N/A
the Prevention of Contrast-Induced Nephropathy by Atrial Natriuretic Peptide in Endovascular Aneurysm Repair.patients underwent endovascular aneurysm repair
JPRN-UMIN000003909Jikei University, School of Medicine Department of Surgery, Vascular Surgery50
Completed
Phase 3
prevention of kidney injury caused by contrast media during angioplasty/graphy by adminstration of sodium potassium citrate solutiocontrast induced nephropathy.Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions
IRCT2015050322065N1Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences190